<code id='DB3E599DF5'></code><style id='DB3E599DF5'></style>
    • <acronym id='DB3E599DF5'></acronym>
      <center id='DB3E599DF5'><center id='DB3E599DF5'><tfoot id='DB3E599DF5'></tfoot></center><abbr id='DB3E599DF5'><dir id='DB3E599DF5'><tfoot id='DB3E599DF5'></tfoot><noframes id='DB3E599DF5'>

    • <optgroup id='DB3E599DF5'><strike id='DB3E599DF5'><sup id='DB3E599DF5'></sup></strike><code id='DB3E599DF5'></code></optgroup>
        1. <b id='DB3E599DF5'><label id='DB3E599DF5'><select id='DB3E599DF5'><dt id='DB3E599DF5'><span id='DB3E599DF5'></span></dt></select></label></b><u id='DB3E599DF5'></u>
          <i id='DB3E599DF5'><strike id='DB3E599DF5'><tt id='DB3E599DF5'><pre id='DB3E599DF5'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:177
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          How neuroscience research could help beat back brain cancer
          How neuroscience research could help beat back brain cancer

          NewresearchledbyStanfordneuro-oncologistMichelleMonjeshineslightontheelectrochemicalsignalingpathway

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Coloradans with cystic fibrosis could lose access to Trikafta

          Illustration:STAT;Source:BusinessWire/APIwaslivingontheprecipiceofend-stagediseasewhenIenrolledinthe